May 2026 in “Indian Dermatology Online Journal” In this case report, a 66-year-old woman with rheumatoid arthritis developed cutaneous ulceration attributed to leflunomide treatment, which significantly healed after discontinuing the drug and administering cholestyramine, underscoring the need for careful monitoring of leflunomide's adverse effects.
2 citations
,
January 2023 in “SAGE Open Medical Case Reports” In this case report, discontinuing leflunomide resolved chronic cutaneous ulcers in a 67-year-old woman, suggesting a potential link between long-term leflunomide use and ulcer formation.
2 citations
,
August 2022 in “Federal Practitioner” This case report describes a patient with lamotrigine-associated drug-induced hypersensitivity syndrome requiring prolonged and complex treatment, with observed complications including extensive alopecia areata and autoimmune thyroiditis.
January 2010 in “Chinese Medical Journal of Metallurgical Industry” This study found that leflunomide combined with prednisone showed good efficacy and tolerance in treating lupus nephritis where cyclophosphamide was ineffective or intolerable.
1 citations
,
June 2013 in “Annals of the Rheumatic Diseases” This study observed that while all DMARD regimens had similar safety profiles, the leflunomide group experienced the most serious side effects leading to therapy discontinuation.